Clinical Study to Evaluate Debio0123 + Sacituzumab Govitecan Combination in TNBC or HR+/HER2- Advanced Breast Cancer
Clinical trial NCT06612203 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06612203
- Sponsor
- MedSIR
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-17
- Primary completion
- 2027-02-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.